Vascular diseases constitute a significant contributor to worldwide mortality rates, placing a
substantial strain on healthcare systems and socio-economic aspects. They are closely …

Cardiovascular disease (CVD), exemplified by coronary artery disease (CAD), is a global
health concern, escalating in prevalence and burden. The etiology of CAD is intricate …

Background Percutaneous coronary intervention (PCI) with drug‐eluting stent (DES)
implantation is a widely adopted strategy for the treatment of de novo coronary artery …

The incidence of coronary heart disease (CAD) has soared over the years, and coronary
intervention has become an increasingly important therapeutic approach. The past decade …

Background and objectives Recent data have established non-inferiority of drug-coated
balloons (DCB) compared to drug-eluting stents (DES) for treatment of small-vessel …

Background ST-segment elevation myocardial infarction (STEMI) is treated with stenting, but
the underlying stenosis is often not severe, and stenting may potentially be omitted. Aims …

Background Data on drug-coated balloon (DCB) treatment in the context of diabetes mellitus
(DM) and multivessel coronary artery disease (CAD) are limited. We aimed to investigate the …

The interventional treatment of coronary artery disease (CAD) has undergone significant
improvements thanks to technological innovations. Nowadays, percutaneous coronary …

Background Whether the drug‐coated balloons (DCBs)‐alone strategy was superior to plain
old balloon angioplasty (POBA) in treating SVD remains unknown. Aims We aimed to …

Background The outcomes of percutaneous coronary intervention (PCI) in diabetic patients
are still suboptimal, and it is unclear if diabetic patients might derive a benefit from the use of …